Literature DB >> 21862643

The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.

Sanja Pajovic1, Timothy W Corson, Clarellen Spencer, Helen Dimaras, Marija Orlic-Milacic, Mellone N Marchong, Kwong-Him To, Brigitte Thériault, Mark Auspitz, Brenda L Gallie.   

Abstract

PURPOSE: Human retinoblastoma arises from an undefined developing retinal cell after inactivation of RB1. This is emulated in a murine retinoblastoma model by inactivation of pRB by retinal-specific expression of simian virus 40 large T-antigen (TAg-RB). Some mutational events after RB1 loss in humans are recapitulated at the expression level in TAg-RB, supporting preclinical evidence that this model is useful for comparative studies between mouse and human. Here, the characteristics of the TAg-RB cell of origin are defined.
METHODS: TAg-RB mice were killed at ages from embryonic day (E)18 to postnatal day (P)35. Tumors were analyzed by immunostaining, DNA copy number PCR, or real-time quantitative RT-PCR for TAg protein, retinal cell type markers, and retinoblastoma-relevant genes.
RESULTS: TAg expression began at P8 in a row of inner nuclear layer cells that increased in number through P21 to P28, when clusters reminiscent of small tumors emerged from cells that escaped a wave of apoptosis. Early TAg-expressing cells coexpressed the developmental marker Chx10 and glial markers CRALBP, clusterin, and carbonic anhydrase II (Car2), but not TuJ1, an early neuronal marker. Emerging tumors retained expression of only Chx10 and carbonic anhydrase II. As with human retinoblastoma, TAg-RB tumors showed decreased Cdh11 DNA copy number and gain of Kif14 and Mycn. It was confirmed that TAg-RB tumors lose expression of tumor suppressor cadherin-11 and overexpress oncogenes Kif14, Dek, and E2f3.
CONCLUSIONS: TAg-RB tumors displayed molecular similarity to human retinoblastoma and origin in a cell with features of differentiated Müller glia with progenitor properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862643      PMCID: PMC3183982          DOI: 10.1167/iovs.11-7989

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  59 in total

1.  Extra-embryonic function of Rb is essential for embryonic development and viability.

Authors:  Lizhao Wu; Alain de Bruin; Harold I Saavedra; Maja Starovic; Anthony Trimboli; Ying Yang; Jana Opavska; Pamela Wilson; John C Thompson; Michael C Ostrowski; Thomas J Rosol; Laura A Woollett; Michael Weinstein; James C Cross; Michael L Robinson; Gustavo Leone
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

Review 2.  Cellular transformation by SV40 large T antigen: interaction with host proteins.

Authors:  S H Ali; J A DeCaprio
Journal:  Semin Cancer Biol       Date:  2001-02       Impact factor: 15.707

3.  Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors.

Authors:  Samuel K Houston; Yolanda Pina; Jennifer Clarke; Tulay Koru-Sengul; William K Scott; Lubov Nathanson; Amy C Schefler; Timothy G Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-23       Impact factor: 4.799

Review 4.  Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer.

Authors:  D DiCiommo; B L Gallie; R Bremner
Journal:  Semin Cancer Biol       Date:  2000-08       Impact factor: 15.707

5.  Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma.

Authors:  Mellone N Marchong; Danian Chen; Timothy W Corson; Cheong Lee; Maria Harmandayan; Ella Bowles; Ning Chen; Brenda L Gallie
Journal:  Mol Cancer Res       Date:  2004-09       Impact factor: 5.852

6.  Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma.

Authors:  Danian Chen; Izhar Livne-bar; Jackie L Vanderluit; Ruth S Slack; Mahima Agochiya; Rod Bremner
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

Review 7.  Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.

Authors:  Christos D Katsetos; Agustin Legido; Elias Perentes; Sverre J Mörk
Journal:  J Child Neurol       Date:  2003-12       Impact factor: 1.987

8.  Cell type-specific effects of Rb deletion in the murine retina.

Authors:  David MacPherson; Julien Sage; Teresa Kim; Dennis Ho; Margaret E McLaughlin; Tyler Jacks
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

9.  Genetic analysis of the homeodomain transcription factor Chx10 in the retina using a novel multifunctional BAC transgenic mouse reporter.

Authors:  Sheldon Rowan; Constance L Cepko
Journal:  Dev Biol       Date:  2004-07-15       Impact factor: 3.582

10.  Genomic analysis of mouse retinal development.

Authors:  Seth Blackshaw; Sanjiv Harpavat; Jeff Trimarchi; Li Cai; Haiyan Huang; Winston P Kuo; Griffin Weber; Kyungjoon Lee; Rebecca E Fraioli; Seo-Hee Cho; Rachel Yung; Elizabeth Asch; Lucila Ohno-Machado; Wing H Wong; Constance L Cepko
Journal:  PLoS Biol       Date:  2004-06-29       Impact factor: 8.029

View more
  13 in total

1.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

2.  Kif14 overexpression accelerates murine retinoblastoma development.

Authors:  Michael O'Hare; Mehdi Shadmand; Rania S Sulaiman; Kamakshi Sishtla; Toshiaki Sakisaka; Timothy W Corson
Journal:  Int J Cancer       Date:  2016-06-24       Impact factor: 7.396

Review 3.  Transgenic Models in Retinoblastoma Research.

Authors:  Rohini M Nair; Geeta K Vemuganti
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

Review 4.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

Review 5.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

6.  Animal models in retinoblastoma research.

Authors:  Rohini M Nair; Swathi Kaliki; Geeta K Vemuganti
Journal:  Saudi J Ophthalmol       Date:  2013-07

7.  Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma.

Authors:  Andrea A Wenzel; Michael N O'Hare; Mehdi Shadmand; Timothy W Corson
Journal:  Mol Vis       Date:  2015-05-01       Impact factor: 2.367

8.  Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.

Authors:  Nathalie Allaman-Pillet; Anne Oberson; Daniel F Schorderet
Journal:  Oncotarget       Date:  2017-02-28

9.  Gene expression profiling identifies different sub-types of retinoblastoma.

Authors:  G Kapatai; M-A Brundler; H Jenkinson; P Kearns; M Parulekar; A C Peet; C M McConville
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

10.  Atypical intravitreal growth of retinoblastoma with a multi-branching configuration.

Authors:  Sachiko Nishina; Satoshi Katagiri; Atsuko Nakazawa; Chikako Kiyotani; Tadashi Yokoi; Noriyuki Azuma
Journal:  Am J Ophthalmol Case Rep       Date:  2017-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.